<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2859">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04416373</url>
  </required_header>
  <id_info>
    <org_study_id>COVID&amp;PREG</org_study_id>
    <nct_id>NCT04416373</nct_id>
  </id_info>
  <brief_title>COVID-19 and Pregnancy Outcomes</brief_title>
  <acronym>COVID&amp;PREG</acronym>
  <official_title>COVID-19 and Pregnancy Outcomes: a Portuguese Collaboration Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Nova de Lisboa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Nova de Lisboa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter prospective study that aims to investigate the clinical impact of
      SARS-CoV-2 infection in pregnant women, pregnancy outcomes and perinatal transmission.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a cohort study of pregnant women confirmed positive for SARS-CoV-2 infection. Data
      will be collected in Portuguese maternities that agreed to collaborate in this study.

      Pregnant women are tested during hospital admission by using nasopharyngeal/oral swabs for
      SARS-CoV-2 RT PCR as part of a universal testing policy. Maternal demographic data (age,
      comorbidities, parity, smoking habits), COVID-19 related data (symptoms, diagnostic tests,
      therapy used and ICU admission), gestational age at SARS-CoV-2 confirmed infection, pregnancy
      outcomes (gestational complications, gestational age at birth, mode of delivery) and neonatal
      outcome (birthweight and Apgar score, RT PCR neonate results) and breastfeeding strategies
      will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 22, 2020</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SARS-CoV-2 Neonatal Infection</measure>
    <time_frame>7 days</time_frame>
    <description>Positive Sars-Cov-2 RT PCR in nasopharyngeal/oral swab tests or presence of IgM in blood samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perinatal mortality</measure>
    <time_frame>35 weeks</time_frame>
    <description>stillbirths and deaths in the first week of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU maternal admission</measure>
    <time_frame>35 weeks</time_frame>
    <description>maternal ICU admission due to COVID-19</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>5 minute Apgar Score &lt; 7</measure>
    <time_frame>1 day</time_frame>
    <description>Newborn 5 minute Apgar Score &lt; 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preterm labour</measure>
    <time_frame>35 weeks</time_frame>
    <description>Delivery between 24 and 36 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PPROM</measure>
    <time_frame>35 weeks</time_frame>
    <description>Preterm premature rupture of the membranes between 24 and 36 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Miscarriage</measure>
    <time_frame>14 weeks</time_frame>
    <description>spontaneous pregnancy loss before 24 weeks</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Coronavirus Infection</condition>
  <condition>Pregnancy Complications</condition>
  <condition>Vertical Transmission of Infectious Disease</condition>
  <condition>Breastfeeding</condition>
  <condition>Neonatal Infection</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>RT PCR SARS-CoV-2</intervention_name>
    <description>Positive SARS-CoV-2 RT PCR in nasopharyngeal/oral swab tests or presence of IgM in blood samples</description>
    <other_name>SARS-COV-2 Serologic test</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women infected with Sars-Cov-2 from 6 to 41 weeks.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: Pregnant women infected with Sars-Cov-2. Delivery at Portuguese
        maternities.

        Exclusion Criteria: RT PCR SARS-CoV-2 negative.

        -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nadia Charepe, MD,MSc</last_name>
    <phone>00351213184000</phone>
    <email>nadia.charepe@chlc.min-saude.pt</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexandra Queirós, MD</last_name>
    <phone>00351213184000</phone>
    <email>alexandra.queiros@nms.unl.pt</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nova Medical School - UNL</name>
      <address>
        <city>Lisbon</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadia Charepe, MSc, MD</last_name>
      <phone>00351213184000</phone>
      <email>nadia.charepe@chlc.min-saude.pt</email>
    </contact>
    <contact_backup>
      <last_name>Alexandra Queirós, MD</last_name>
      <phone>00351213184000</phone>
      <email>alexandra.queiros@nms.unl.pt</email>
    </contact_backup>
    <investigator>
      <last_name>Ana M Campos, PhD,MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nadia Charepe, MSc, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandra S Queiros, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria J Alves, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Teresa Ventura, PhD,MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 29, 2020</study_first_submitted>
  <study_first_submitted_qc>June 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2020</study_first_posted>
  <last_update_submitted>June 3, 2020</last_update_submitted>
  <last_update_submitted_qc>June 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Pregnancy Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

